Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Rita Danesi"'
Autor:
Giovanni Innella, Cristina Fortuno, Laura Caleca, Bing‐Jian Feng, Courtney Carroll, Michael T. Parsons, Sara Miccoli, Marco Montagna, Daniele Calistri, Laura Cortesi, Barbara Pasini, Siranoush Manoukian, Daniela Giachino, Laura Matricardi, Maria Cristina Foti, Valentina Zampiga, Claudia Piombino, Elena Barbieri, Francesca Vignolo Lutati, Jacopo Azzolini, Rita Danesi, Valentina Arcangeli, Sandrine M. Caputo, Nadia Boutry‐Kryza, Vincent Goussot, Susan Hiraki, Marcy Richardson, Hereditary Breast/Ovarian Cancer IOV network (HBOC IOVnet), Simona Ferrari, Paolo Radice, Amanda B. Spurdle, Daniela Turchetti
Publikováno v:
Cancer Medicine, Vol 13, Iss 16, Pp n/a-n/a (2024)
Abstract Background BRCA1:c.5017_5019del (p.His1673del) is a founder variant relatively frequent in Northern Italy. Despite previous suggestion of pathogenicity, variant classification in public databases is still conflicting, needing additional evid
Externí odkaz:
https://doaj.org/article/32f976e151b24f91bbf40981195926b1
Autor:
Stefano Ferretti, Priscilla Sassoli de Bianchi, Debora Canuti, Cinzia Campari, Laura Cortesi, Valentina Arcangeli, Elena Barbieri, Cecilia D’Aloia, Rita Danesi, Pierandrea De Iaco, Margherita De Lillo, Laura Lombardo, Gabriella Moretti, Antonino Musolino, Dante Palli, Caterina Palmonari, Mila Ravegnani, Alfredo Tafà, Alessandra Tononi, Daniela Turchetti, Claudio Zamagni, Valentina Zampiga, Lauro Bucchi, the HBOC Study Group
Publikováno v:
Methods and Protocols, Vol 7, Iss 4, p 63 (2024)
Hereditary breast/ovarian cancer (HBOC) syndrome is caused by the inheritance of monoallelic germline BRCA1/2 gene mutations. If BRCA1/2 mutation carriers are identified before the disease develops, effective actions against HBOC can be taken, includ
Externí odkaz:
https://doaj.org/article/45a7886160724011a27d7da7efcaef86
Autor:
Erika Bandini, Valentina Zampiga, Ilaria Cangini, Mila Ravegnani, Valentina Arcangeli, Tania Rossi, Isabella Mammi, Francesca Schiavi, Stefania Zovato, Fabio Falcini, Daniele Calistri, Rita Danesi
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 15, p 12418 (2023)
Subjects with pathogenic (PV) and likely pathogenic (LPV) FLCN variants have an increased risk of manifesting benign and malignant disorders that are related to Birt–Hogg–Dubé syndrome (BHDS): an autosomal dominantly inherited disorder whose sev
Externí odkaz:
https://doaj.org/article/5c83db0646ea4bcd81a5485d70c4b266
Autor:
Ilario Giovanni Rapposelli, Valentina Zampiga, Ilaria Cangini, Valentina Arcangeli, Mila Ravegnani, Martina Valgiusti, Sara Pini, Stefano Tamberi, Giulia Bartolini, Alessandro Passardi, Giovanni Martinelli, Daniele Calistri, Giovanni Luca Frassineti, Fabio Falcini, Rita Danesi
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Pancreatic cancer (PC) is a major cause of cancer death. In an effort to improve treatment strategies and outcomes, DNA damage repair (DDR) pathways have been introduced as a new target in PC and in other cancers, through the expl
Externí odkaz:
https://doaj.org/article/eb588727dceb41739f721cc956da76f5
Autor:
Erika Bandini, Ilaria Cangini, Valentina Arcangeli, Mila Ravegnani, Virginia Andreotti, Giovanna Prisinzano, Lorenza Pastorino, Giovanni Martinelli, Fabio Falcini, Daniele Calistri, Valentina Zampiga, Rita Danesi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Birt–Hogg–Dubé syndrome (BHDS) is a rare autosomal dominant inherited disorder caused by a mutation in folliculin (FLCN) gene transmitted via germline autosomal dominant pattern. Patients with this syndrome have an increased susceptibility to re
Externí odkaz:
https://doaj.org/article/1d148c0101d04f9e91aece46a508a586
Autor:
Giorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi, Elisabetta Petracci, Claudia Casanova, Giuseppe Comerci, Rita Danesi, Valentina Arcangeli, Mila Ravegnani, Daniele Calistri, Valentina Zampiga, Ilaria Cangini, Eugenio Fonzi, Alessandra Virga, Davide Tassinari, Marta Rosati, Paola Ulivi, Ugo De Giorgi
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 24, p 15789 (2022)
BRCA1 and BRCA2 are the most frequently mutated genes in ovarian cancer (OC) crucial both for the identification of cancer predisposition and therapeutic choices. However, germline variants in other genes could be involved in OC susceptibility. We ch
Externí odkaz:
https://doaj.org/article/7fbc536868564023ba36fba7fbe7cd74
Autor:
Gianluca Tedaldi, Chiara Molinari, Celina São José, Rita Barbosa-Matos, Ana André, Rita Danesi, Valentina Arcangeli, Mila Ravegnani, Luca Saragoni, Paolo Morgagni, Francesca Rebuzzi, Matteo Canale, Sara Pignatta, Elisa Ferracci, Giovanni Martinelli, Guglielmina Nadia Ranzani, Carla Oliveira, Daniele Calistri, Paola Ulivi
Publikováno v:
Pharmaceuticals, Vol 14, Iss 5, p 457 (2021)
E-cadherin is a key player in gastric cancer (GC) and germline alterations of CDH1, its encoding gene, are responsible for Hereditary Diffuse Gastric Cancer (HDGC) syndrome. This study aimed at elucidating the role of genetic variants and DNA methyla
Externí odkaz:
https://doaj.org/article/93314491ddb043b1bf1a47a691c33b20
Autor:
Gianluca Tedaldi, Michela Tebaldi, Valentina Zampiga, Ilaria Cangini, Francesca Pirini, Elisa Ferracci, Rita Danesi, Valentina Arcangeli, Mila Ravegnani, Giovanni Martinelli, Fabio Falcini, Paola Ulivi, Daniele Calistri
Publikováno v:
Diagnostics, Vol 10, Iss 5, p 269 (2020)
Male breast cancer (MBC) is a rare tumor, accounting for less than 1% of all breast cancers. In MBC, genetic predisposition plays an important role; however, only a few studies have investigated in depth the role of genes other than BRCA1 and BRCA2.
Externí odkaz:
https://doaj.org/article/090132d47eda42eba37e152d9c7ba746
Autor:
Valentina Zampiga, Ilaria Cangini, Erika Bandini, Irene Azzali, Mila Ravegnani, Alessandra Ravaioli, Silvia Mancini, Michela Tebaldi, Gianluca Tedaldi, Francesca Pirini, Luigi Veneroni, Giovanni Luca Frassineti, Fabio Falcini, Rita Danesi, Daniele Calistri, Valentina Arcangeli
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2132
PVs and LPVs in BRCA1/2 genes are correlated to a high risk of developing breast cancer and/or ovarian cancer (Hereditary Breast and Ovarian Cancer syndrome, HBOC); additionally, in recent years, an increasing number of BRCA 1/2 variants have been id
Autor:
Ilaria Cangini, Valentina Arcangeli, Fabio Falcini, Stefano Tamberi, Ilario Giovanni Rapposelli, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Zampiga, Giovanni Martinelli, Daniele Calistri, Martina Valgiusti, Giulia Bartolini, Mila Ravegnani, Sara Pini, Rita Danesi
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Background Pancreatic cancer (PC) is a major cause of cancer death. In an effort to improve treatment strategies and outcomes, DNA damage repair (DDR) pathways have been introduced as a new target in PC and in other cancers, through the exploitation